Super-selective transarterial chemoembolization of hepatocellular carcinoma with doxorubicin-eluting beads sized 40–75 microns: assessment of efficacy and safety | Zendy

Hüseyin Tuğsan Ballı | Zendy; Kairgeldy Aikimbaev | Zendy

Open Access

Super-selective transarterial chemoembolization of hepatocellular carcinoma with doxorubicin-eluting beads sized 40–75 microns: assessment of efficacy and safety

Author(s) -

Hüseyin Tuğsan Ballı,

Kairgeldy Aikimbaev

Publication year - 2020

Publication title -

diagnostic and interventional radiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.754

H-Index - 43

eISSN - 1305-3612

pISSN - 1305-3825

DOI - 10.5152/dir.2020.19410

Subject(s) - medicine , hepatocellular carcinoma , response evaluation criteria in solid tumors , liver transplantation , liver cancer , adverse effect , single center , progressive disease , retrospective cohort study , doxorubicin , radiology , surgery , transplantation , nuclear medicine , chemotherapy

We aimed to evaluate the effectiveness and safety of super-selective transarterial chemoembolization (TACE) with doxorubicin-loaded drug-eluting beads (DEB) sized 40-75 μm for hepatocellular carcinoma (HCC) in early and intermediate stages according to Barcelona Clinic Liver Cancer (BCLC) staging system.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research